Francesco De Marchis

Francesco De Marchis

Auto-generated profile, based on publicly available information

Francesco De Marchis

Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milan, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2012 in Journal of Experimental Medicine
Verified
Journal Article
Open access
EVEmilie Venereau
Emilie Venereau
MCMaura Casalgrandi
Maura Casalgrandi
MSMilena Schiraldi
Milena Schiraldi
DADaniel J. Antoine
Daniel J. Antoine
ACAngela Cattaneo
Angela Cattaneo
MBMarco E. Bianchi
Marco E. Bianchi
Tissue damage causes inflammation, by recruiting leukocytes and activating them to release proinflammatory mediators. We show that high-mobility group box 1 protein (HMGB1) orchestrates both processes by switching among mutually exclusive redox states. Reduced cysteines make HMGB1 a chemoattractant, whereas a disulfide bond makes it a proinflammatory cytokine and further cysteine oxidation to sulfonates by reactive oxygen species abrogates both activities. We show that leukocyte recruitment and activation can be separated. A nonoxidizable HMGB1 mutant in which serines replace all cysteines (3S-HMGB1) does not promote cytokine production, but is more effective than wild-type HMGB1 in recruiting leukocytes in vivo. BoxA, a HMGB1 inhibitor, interferes with leukocyte recruitment but not with activation. We detected the different redox forms of HMGB1 ex vivo within injured muscle. HMGB1 is completely reduced at first and disulfide-bonded later. Thus, HMGB1 orchestrates both key events in sterile inflammation, leukocyte recruitment and their induction to secrete inflammatory cytokines, by adopting mutually exclusive redox states.

27 February 2012 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MSMilena Schiraldi
Milena Schiraldi
ARAngela Raucci
Angela Raucci
LMLaura Martínez Muñoz
Laura Martínez Muñoz
ELElsa Livoti
Elsa Livoti
BCBarbara Celona
Barbara Celona
MUMariagrazia Uguccioni
Mariagrazia Uguccioni
After tissue damage, inflammatory cells infiltrate the tissue and release proinflammatory cytokines. HMGB1 (high mobility group box 1), a nuclear protein released by necrotic and severely stressed cells, promotes cytokine release via its interaction with the TLR4 (Toll-like receptor 4) receptor and cell migration via an unknown mechanism. We show that HMGB1-induced recruitment of inflammatory cells depends on CXCL12. HMGB1 and CXCL12 form a heterocomplex, which we characterized by nuclear magnetic resonance and surface plasmon resonance, that acts exclusively through CXCR4 and not through other HMGB1 receptors. Fluorescence resonance energy transfer data show that the HMGB1–CXCL12 heterocomplex promotes different conformational rearrangements of CXCR4 from that of CXCL12 alone. Mononuclear cell recruitment in vivo into air pouches and injured muscles depends on the heterocomplex and is inhibited by AMD3100 and glycyrrhizin. Thus, inflammatory cell recruitment and activation both depend on HMGB1 via different mechanisms.

1 April 2007 in Chemistry & Biology
Verified
Journal Article
Closed access
LMLuca Mollica
Luca Mollica
FMFrancesco De Marchis
Francesco De Marchis
ASAndrea Spitaleri
Andrea Spitaleri
CDCorrado Dallacosta
Corrado Dallacosta
DPDanilo Pennacchini
Danilo Pennacchini
MBMarco E. Bianchi
Marco E. Bianchi

8 December 2008 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
VUVilma Urbonaviciute
Vilma Urbonaviciute
BFBarbara G. Fürnrohr
Barbara G. Fürnrohr
SMSilke Meister
Silke Meister
Luis MunozLuis Munoz
Luis Munoz
PHPetra Heyder
Petra Heyder
RVReinhard E. Voll
Reinhard E. Voll
Autoantibodies against double-stranded DNA (dsDNA) and nucleosomes represent a hallmark of systemic lupus erythematosus (SLE). However, the mechanisms involved in breaking the immunological tolerance against these poorly immunogenic nuclear components are not fully understood. Impaired phagocytosis of apoptotic cells with consecutive release of nuclear antigens may contribute to the immune pathogenesis. The architectural chromosomal protein and proinflammatory mediator high mobility group box protein 1 (HMGB1) is tightly attached to the chromatin of apoptotic cells. We demonstrate that HMGB1 remains bound to nucleosomes released from late apoptotic cells in vitro. HMGB1–nucleosome complexes were also detected in plasma from SLE patients. HMGB1-containing nucleosomes from apoptotic cells induced secretion of interleukin (IL) 1β, IL-6, IL-10, and tumor necrosis factor (TNF) α and expression of costimulatory molecules in macrophages and dendritic cells (DC), respectively. Neither HMGB1-free nucleosomes from viable cells nor nucleosomes from apoptotic cells lacking HMGB1 induced cytokine production or DC activation. HMGB1-containing nucleosomes from apoptotic cells induced anti-dsDNA and antihistone IgG responses in a Toll-like receptor (TLR) 2–dependent manner, whereas nucleosomes from living cells did not. In conclusion, HMGB1–nucleosome complexes activate antigen presenting cells and, thereby, may crucially contribute to the pathogenesis of SLE via breaking the immunological tolerance against nucleosomes/dsDNA.

26 January 2004 in Journal of Cell Biology
Verified
Journal Article
Open access
RPRoberta Palumbo
Roberta Palumbo
Maurilio SampaolesiMaurilio Sampaolesi
Maurilio Sampaolesi
FMFrancesco De Marchis
Francesco De Marchis
RTRossana Tonlorenzi
Rossana Tonlorenzi
SCSara Colombetti
Sara Colombetti
MBMarco E. Bianchi
Marco E. Bianchi
High mobility group box 1 (HMGB1) is an abundant chromatin protein that acts as a cytokine when released in the extracellular milieu by necrotic and inflammatory cells. Here, we show that extracellular HMGB1 and its receptor for advanced glycation end products (RAGE) induce both migration and proliferation of vessel-associated stem cells (mesoangioblasts), and thus may play a role in muscle tissue regeneration. In vitro, HMGB1 induces migration and proliferation of both adult and embryonic mesoangioblasts, and disrupts the barrier function of endothelial monolayers. In living mice, mesoangioblasts injected into the femoral artery migrate close to HMGB1-loaded heparin-Sepharose beads implanted in healthy muscle, but are unresponsive to control beads. Interestingly, α-sarcoglycan null dystrophic muscle contains elevated levels of HMGB1; however, mesoangioblasts migrate into dystrophic muscle even if their RAGE receptor is disabled. This implies that the HMGB1–RAGE interaction is sufficient, but not necessary, for mesoangioblast homing; a different pathway might coexist. Although the role of endogenous HMGB1 in the reconstruction of dystrophic muscle remains to be clarified, injected HMGB1 may be used to promote tissue regeneration.

8 October 2007 in Journal of Cell Biology
Verified
Journal Article
Open access
RPRoberta Palumbo
Roberta Palumbo
Beatriz G. GalvezBeatriz G. Galvez
Beatriz G. Galvez
TPTobias Pusterla
Tobias Pusterla
FMFrancesco De Marchis
Francesco De Marchis
GCGiulio Cossu
Giulio Cossu
MBMarco E. Bianchi
Marco E. Bianchi
Tissue damage is usually followed by healing, as both differentiated and stem cells migrate to replace dead or damaged cells. Mesoangioblasts (vessel-associated stem cells that can repair muscles) and fibroblasts migrate toward soluble factors released by damaged tissue. Two such factors are high mobility group box 1 (HMGB1), a nuclear protein that is released by cells undergoing unscheduled death (necrosis) but not by apoptotic cells, and stromal derived factor (SDF)–1/CXCL12. We find that HMGB1 activates the canonical nuclear factor κB (NF-κB) pathway via extracellular signal-regulated kinase phosphorylation. NF-κB signaling is necessary for chemotaxis toward HMGB1 and SDF-1/CXCL12, but not toward growth factor platelet-derived growth factor, formyl-met-leu-phe (a peptide that mimics bacterial invasion), or the archetypal NF-κB–activating signal tumor necrosis factor α. In dystrophic mice, mesoangioblasts injected into the general circulation ingress inefficiently into muscles if their NF-κB signaling pathway is disabled. These findings suggest that NF-κB signaling controls tissue regeneration in addition to early events in inflammation.